Bacteriophages and their applications in the diagnosis and treatment of hepatitis B virus infection

World Journal of Gastroenterology

Volumn 20, Issue 33, 2014, Pages 11671-11683

  Bakhshinejad, Babak ^a   Sadeghizadeh, Majid ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Bacteriophage; Biopanning; Diagnosis; Hepatitis b virus; Phage display; Phage library; Treatment; Vaccine development

Indexed keywords

HEPATITIS VACCINE; ANTIVIRUS AGENT; HEPATITIS B VACCINE;

BACTERIOPHAGE; COMBINATORIAL LIBRARY; HEPATITIS B; HUMAN; NONHUMAN; PHAGE DISPLAY; REVIEW; ANIMAL; CELL SURFACE DISPLAY; DRUG DESIGN; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; HEPATITIS B VIRUS; MOLECULARLY TARGETED THERAPY; PATHOGENICITY; PREDICTIVE VALUE;

ANIMALS; ANTIVIRAL AGENTS; BACTERIOPHAGES; CELL SURFACE DISPLAY TECHNIQUES; DRUG DESIGN; GENE EXPRESSION REGULATION, VIRAL; GENOTYPE; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; MOLECULAR TARGETED THERAPY; PREDICTIVE VALUE OF TESTS;

EID: 84909637319     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i33.11671     Document Type: Review

References (99)

1. Wright TL. Introduction to chronic hepatitis B infection. Am J Gastroenterol 2006; 101 Suppl 1: S1-S6 [PMID: 16448446 DOI: 10.1111/j.1572-0241.2006.00469.x]
2. Petersen J , Dandri M, Mier W, Lütgehetmann M, Volz T, von Weizsäcker F, Haberkorn U, Fischer L, Pollok JM, Erbes B, Seitz S, Urban S. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat Biotechnol 2008; 26: 335-341 [PMID: 18297057 DOI: 10.1038/nbt1389]
3. Tan WS , Tan GH, Yusoff K, Seow HF. A phage-displayed cyclic peptide that interacts tightly with the immunodominant region of hepatitis B surface antigen. J Clin Virol 2005; 34: 35-41 [PMID: 16087122 DOI: 10.1016/j.jcv.2005.01.007]
4. Xie Y, Zhai J, Deng Q, Tiollais P, Wang Y, Zhao M. Entry of hepatitis B virus: mechanism and new therapeutic target. Pathol Biol (Paris) 2010; 58: 301-307 [PMID: 20570056 DOI: 10.1016/j.patbio.2010.04.001]
5. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006; 28: 112-125 [PMID: 16754644 DOI: 10.1093/epirev/mxj009]
6. Ganem D . Assembly of hepadnaviral virions and subviral particles. Curr Top Microbiol Immunol 1991; 168: 61-83 [PMID: 1893779 DOI: 10.1007/978-3-642-76015-0-4]
7. Dabrowska K, Switała-Jelen K, Opolski A, Weber-Dabrowska B, Gorski A. Bacteriophage penetration in vertebrates. J Appl Microbiol 2005; 98: 7-13 [PMID: 15610412 DOI: 10.1111/j.1365-2672.2004.02422.x]
8. Solomon B. Filamentous bacteriophage as a novel therapeutic tool for Alzheimer's disease treatment. J Alzheimers Dis 2008; 15: 193-198 [PMID: 18953108]
9. Hambly E , Suttle CA. The viriosphere, diversity, and genetic exchange within phage communities. Curr Opin Microbiol 2005; 8: 444-450 [PMID: 15979387 DOI: 10.1016/j.mib.2005.06.005]
10. Clark JR , March JB. Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials. Trends Biotechnol 2006; 24: 212-218 [PMID: 16567009 DOI: 10.1016/j.tibtech.2006.03.003]
11. Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985; 228: 1315-1317 [PMID: 4001944 DOI: 10.1126/science.4001944]
12. Paschke M. Phage display systems and their applications. Appl Microbiol Biotechnol 2006; 70: 2-11 [PMID: 16365766 DOI: 10.1007/s00253-005-0270-9]
13. Pande J, Szewczyk MM, Grover AK. Phage display: concept, innovations, applications and future. Biotechnol Adv 2010; 28: 849-858 [PMID: 20659548 DOI: 10.1016/j.biotechadv.2010.07.004]
14. Barbas CF, Kang AS, Lerner RA, Benkovic SJ. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci USA 1991; 88: 7978-7982 [PMID: 1896445 DOI: 10.1073/pnas.88.18.7978]
15. Burritt JB, Bond CW, Doss KW, Jesaitis AJ. Filamentous phage display of oligopeptide libraries. Anal Biochem 1996; 238: 1-13 [PMID: 8660577 DOI: 10.1006/abio.1996.0241]
16. Winter G , Griffiths AD, Hawkins RE, Hoogenboom HR. Making antibodies by phage display technology. Annu Rev Immunol 1994; 12: 433-455 [PMID: 8011287 DOI: 10.1146/annurev.iy.12.040194.002245]
17. Tohidkia MR, Barar J, Asadi F, Omidi Y. Molecular considerations for development of phage antibody libraries. J Drug Target 2012; 20: 195-208 [PMID: 21950316 DOI: 10.3109/1061186X.2011.611517]
18. Krumpe LR, Mori T. The Use of Phage-Displayed Peptide Libraries to Develop Tumor-Targeting Drugs. Int J Pept Res Ther 2006; 12: 79-91 [PMID: 19444323 DOI: 10.1007/s10989-005-9002-3]
19. Hertveldt K, Beliën T, Volckaert G. General M13 phage display: M13 phage display in identification and characterization of protein-protein interactions. Methods Mol Biol 2009; 502: 321-339 [PMID: 19082565 DOI: 10.1007/978-1-60327-565-1-19]
20. Manoutcharian K , Gevorkian G, Cano A, Almagro JC. Phage displayed biomolecules as preventive and therapeutic agents. Curr Pharm Biotechnol 2001; 2: 217-223 [PMID: 11530876 DOI: 10.2174/1389201013378671]
21. Sergeeva A, Kolonin MG, Molldrem JJ, Pasqualini R, Arap W. Display technologies: application for the discovery of drug and gene delivery agents. Adv Drug Deliv Rev 2006; 58: 1622-1654 [PMID: 17123658 DOI: 10.1016/j.addr.2006.09.018]
22. Mao C, Liu A, Cao B. Virus-based chemical and biological sensing. Angew Chem Int Ed Engl 2009; 48: 6790-6810 [PMID: 19662666 DOI: 10.1002/anie.200900231]
23. Ahmadvand D , Rahbarizadeh F, Moghimi SM. Biological targeting and innovative therapeutic interventions with phage-displayed peptides and structured nucleic acids (aptamers). Curr Opin Biotechnol 2011; 22: 832-838 [PMID: 21420292 DOI: 10.1016/j.copbio.2011.02.012]
24. Li K, Nguyen HG, Lu X, Wang Q. Viruses and their potential in bioimaging and biosensing applications. Analyst 2010; 135: 21-27 [PMID: 20024176 DOI: 10.1039/b911883g]
25. Castel G, Chtéoui M, Heyd B, Tordo N. Phage display of combinatorial peptide libraries: application to antiviral research. Molecules 2011; 16: 3499-3518 [PMID: 21522083 DOI: 10.3390/molecules16053499]
26. Willats WG. Phage display: practicalities and prospects. Plant Mol Biol 2002; 50: 837-854 [PMID: 12516857]
27. Prisco A, De Berardinis P. Filamentous bacteriophage fd as an antigen delivery system in vaccination. Int J Mol Sci 2012; 13: 5179-5194 [PMID: 22606037 DOI: 10.3390/ijms13045179]
28. Hamzeh-Mivehroud M, Alizadeh AA, Morris MB, Church WB, Dastmalchi S. Phage display as a technology delivering on the promise of peptide drug discovery. Drug Discov Today 2013; 18: 1144-1157 [PMID: 24051398 DOI: 10.1016/j.drudis.2013.09.001]
29. Kehoe JW, Kay BK. Filamentous phage display in the new millennium. Chem Rev 2005; 105: 4056-4072 [PMID: 16277371 DOI: 10.1021/cr000261r]
30. Landon LA , Deutscher SL. Combinatorial discovery of tumor targeting peptides using phage display. J Cell Biochem 2003; 90: 509-517 [PMID: 14523985 DOI: 10.1002/jcb.10634]
31. Houghten RA, Pinilla C, Blondelle SE, Appel JR, Dooley CT, Cuervo JH. Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature 1991; 354: 84-86 [PMID: 1719428 DOI: 10.1038/354084a0]
32. Laakkonen P , Vuorinen K. Homing peptides as targeted delivery vehicles. Integr Biol (Camb) 2010; 2: 326-337 [PMID: 20657951]
33. Christianson DR, Ozawa MG, Pasqualini R, Arap W. Techniques to decipher molecular diversity by phage display. Methods Mol Biol 2007; 357: 385-406 [PMID: 17172704]
34. Shukla GS, Krag DN. Phage display selection for cell-specific ligands: development of a screening procedure suitable for small tumor specimens. J Drug Target 2005; 13: 7-18 [PMID: 15848950 DOI: 10.1080/10611860400020464]
35. Staquicini FI, Sidman RL, Arap W, Pasqualini R. Phage display technology for stem cell delivery and systemic therapy. Adv Drug Deliv Rev 2010; 62: 1213-1216 [PMID: 20932865 DOI: 10.1016/j.addr.2010.09.014]
36. Barry MA, Dower WJ, Johnston SA. Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nat Med 1996; 2: 299-305 [PMID: 8612228 DOI: 10.1038/nm0396-299]
37. Kolonin MG, Sun J, Do KA, Vidal CI, Ji Y, Baggerly KA, Pasqualini R, Arap W. Synchronous selection of homing peptides for multiple tissues by in vivo phage display. FASEB J 2006; 20: 979-981 [PMID: 16581960 DOI: 10.1096/fj.05-5186fje]
38. Cortese R , Monaci P, Luzzago A, Santini C, Bartoli F, Cortese I, Fortugno P, Galfrè G, Nicosia A, Felici F. Selection of biologically active peptides by phage display of random peptide libraries. Curr Opin Biotechnol 1996; 7: 616-621 [PMID: 8939640 DOI: 10.1016/S0958-1669(96)80072-3]
39. Zhao S, Zhao W, Ma L. Novel peptide ligands that bind specifically to mouse embryonic stem cells. Peptides 2010; 31: 2027-2034 [PMID: 20713104 DOI: 10.1016/j.peptides.2010.08.004]
40. Derda R, Tang SK, Li SC, Ng S, Matochko W, Jafari MR. Diversity of phage-displayed libraries of peptides during panning and amplification. Molecules 2011; 16: 1776-1803 [PMID: 21339712 DOI: 10.3390/molecules16021776]
41. Marr A, Markert A, Altmann A, Askoxylakis V, Haberkorn U. Biotechnology techniques for the development of new tumor specific peptides. Methods 2011; 55: 215-222 [PMID: 21640826 DOI: 10.1016/j.ymeth.2011.05.002]
42. Newton J, Deutscher SL. Phage peptide display. Handb Exp Pharmacol 2008; (185 Pt 2): 145-163 [PMID: 18626602 DOI: 10.1007/978-3-540-77496-9-7]
43. Sidhu SS. Phage display in pharmaceutical biotechnology. Curr Opin Biotechnol 2000; 11: 610-616 [PMID: 11102798 DOI: 10.1016/S0958-1669(00)00152-X]
44. Deutscher SL . Phage display in molecular imaging and diagnosis of cancer. Chem Rev 2010; 110: 3196-3211 [PMID: 20170129 DOI: 10.1021/cr900317f]
45. Kimura T , Rokuhara A, Matsumoto A, Yagi S, Tanaka E, Kiyosawa K, Maki N. New enzyme immunoassay for detection of hepatitis B virus core antigen (HBcAg) and relation between levels of HBcAg and HBV DNA. J Clin Microbiol 2003; 41: 1901-1906 [PMID: 12734224 DOI: 10.1128/JCM.41.5.1901-1906.2003]
46. Bredehorst R , von Wulffen H, Granato C. Quantitation of hepatitis B virus (HBV) core antigen in serum in the presence of antibodies to HBV core antigen: comparison with assays of serum HBV DNA, DNA polymerase, and HBV e antigen. J Clin Microbiol 1985; 21: 593-598 [PMID: 3988901]
47. Katchaki JN , Siem TH, Brouwer R, Brandt KH, van der Waart M. Detection and significance of anti-HBc in the blood bank; preliminary results of a controlled prospective study. J Virol Methods 1980; 2: 119-125 [PMID: 7228974 DOI: 10.1016/0166-0934(80)90045-2]
48. Bahadir AO, Balcioglu BK, Uzyol KS, Hatipoglu I, Sogut I, Basalp A, Erdag B. Phage displayed HBV core antigen with immunogenic activity. Appl Biochem Biotechnol 2011; 165: 1437-1447 [PMID: 21915589 DOI: 10.1007/s12010-011-9365-1]
49. Hasmoni SS, Yusoff K, Tan WS. Detection and precipitation of hepatitis B core antigen using a fusion bacteriophage. J Gen Appl Microbiol 2005; 51: 125-131 [PMID: 15942873 DOI: 10.2323/jgam.51.125]]
50. Ho KL, Yusoff K, Seow HF, Tan WS. Selection of high affinity ligands to hepatitis B core antigen from a phage-displayed cyclic peptide library. J Med Virol 2003; 69: 27-32 [PMID: 12436474 DOI: 10.1002/jmv.10266]
51. Monjezi R , Tan SW, Tey BT, Sieo CC, Tan WS. Detection of hepatitis B virus core antigen by phage display mediated TaqMan real-time immuno-PCR. J Virol Methods 2013; 187: 121-126 [PMID: 23022731 DOI: 10.1016/j.jviromet.2012.09.017]
52. Guo YC , Zhou YF, Zhang XE, Zhang ZP, Qiao YM, Bi LJ, Wen JK, Liang MF, Zhang JB. Phage display mediated immuno-PCR. Nucleic Acids Res 2006; 34: e62 [PMID: 16682441 DOI: 10.1093/nar/gkl260]
53. Usuda S, Okamoto H, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M. An enzyme-linked immunosorbent assay with monoclonal antibodies for the determination of phosphorylated hepatitis B core protein (p21c) in serum. J Virol Methods 1998; 72: 95-103 [PMID: 9672136 DOI: 10.1016/S0166-0934(98)00019-6]
54. Niemeyer CM, Adler M, Wacker R. Immuno-PCR: high sensitivity detection of proteins by nucleic acid amplification. Trends Biotechnol 2005; 23: 208-216 [PMID: 15780713 DOI: 10.1016/j.tibtech.2005.02.006]
55. Yokoyama-Kobayashi M , Kato S. Recombinant f1 phagemediated transfection of mammalian cells using lipopolyamine technique. Anal Biochem 1994; 223: 130-134 [PMID: 7695088 DOI: 10.1006/abio.1994.1557]
56. Yokoyama-Kobayashi M, Kato S. Recombinant f1 phage particles can transfect monkey COS-7 cells by DEAE dextran method. Biochem Biophys Res Commun 1993; 192: 935-939 [PMID: 8484795 DOI: 10.1006/bbrc.1993.1505]
57. Okayama H, Berg P. Bacteriophage lambda vector for transducing a cDNA clone library into mammalian cells. Mol Cell Biol 1985; 5: 1136-1142 [PMID: 3158804]
58. Hart SL, Knight AM, Harbottle RP, Mistry A, Hunger HD, Cutler DF, Williamson R, Coutelle C. Cell binding and internalization by filamentous phage displaying a cyclic Arg-Gly- Asp-containing peptide. J Biol Chem 1994; 269: 12468-12474 [PMID: 8175653]
59. Larocca D, Kassner PD, Witte A, Ladner RC, Pierce GF, Baird A. Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage. FASEB J 1999; 13: 727-734 [PMID: 10094933]
60. Larocca D, Burg MA, Jensen-Pergakes K, Ravey EP, Gonzalez AM, Baird A. Evolving phage vectors for cell targeted gene delivery. Curr Pharm Biotechnol 2002; 3: 45-57 [PMID: 11883506]
61. Larocca D , Baird A. Receptor-mediated gene transfer by phage-display vectors: applications in functional genomics and gene therapy. Drug Discov Today 2001; 6: 793-801 [PMID: 11470588 DOI: 10.1016/S1359-6446(01)01837-2]
62. Di Giovine M , Salone B, Martina Y, Amati V, Zambruno G, Cundari E, Failla CM, Saggio I. Binding properties, cell delivery, and gene transfer of adenoviral penton base displaying bacteriophage. Virology 2001; 282: 102-112 [PMID: 11259194 DOI: 10.1006/viro.2000.0809]
63. Poul MA, Marks JD. Targeted gene delivery to mammalian cells by filamentous bacteriophage. J Mol Biol 1999; 288: 203-211 [PMID: 10329137 DOI: 10.1006/jmbi.1999.2678]
64. Tang KH , Yusoff K, Tan WS. Display of hepatitis B virus PreS1 peptide on bacteriophage T7 and its potential in gene delivery into HepG2 cells. J Virol Methods 2009; 159: 194-199 [PMID: 19490973 DOI: 10.1016/j.jviromet.2009.03.015]
65. Wang W , Liu Y, Zu X, Jin R, Xiao G. Blocking peptides against HBV: preS1 protein selected from a phage display library. Biochem Biophys Res Commun 2011; 412: 633-637 [PMID: 21856287 DOI: 10.1016/j.bbrc.2011.08.014]
66. Deng Q, Zhuang M, Kong YY, Xie YH, Wang Y. Screening for PreS specific binding ligands with a phage displayed peptides library. World J Gastroenterol 2005; 11: 4018-4023 [PMID: 15996026]
67. Park SG , Jeong YJ, Lee YY, Kim IJ, Seo SK, Kim EJ, Jung HC, Pan JG, Park SJ, Lee YJ, Kim IS, Choi IH. Hepatitis B virus-neutralizing anti-pre-S1 human antibody fragments from large naïve antibody phage library. Antiviral Res 2005; 68: 109-115 [PMID: 16290278 DOI: 10.1016/j.antiviral.2005.06.012]
68. Wen WH , Qin WJ, Gao H, Zhao J, Jia LT, Liao QH, Meng YL, Jin BQ, Yao LB, Chen SY, Yang AG. An hepatitis B virus surface antigen specific single chain of variable fragment derived from a natural immune antigen binding fragment phage display library is specifically internalized by HepG2.2.15 cells. J Viral Hepat 2007; 14: 512-519 [PMID: 17576393 DOI: 10.1111/j.1365-2893.2007.00843.x]
69. Yang GH, Yoon SO, Jang MH, Hong HJ. Affinity maturation of an anti-hepatitis B virus PreS1 humanized antibody by phage display. J Microbiol 2007; 45: 528-533 [PMID: 18176536]
70. Kaplan JM. New cancer vaccine approaches. Drugs Today (Barc) 2004; 40: 913-929 [PMID: 15645004 DOI: 10.1358/dot.2004.40.11.872580]
71. Clark JR , March JB. Bacteriophage-mediated nucleic acid immunisation. FEMS Immunol Med Microbiol 2004; 40: 21-26 [PMID: 14734182 DOI: 10.1016/S0928-8244(03)00344-4]
72. March JB , Clark JR, Jepson CD. Genetic immunisation against hepatitis B using whole bacteriophage lambda particles. Vaccine 2004; 22: 1666-1671 [PMID: 15068849 DOI: 10.1016/j.vaccine.2003.10.047]
73. Jepson CD, March JB. Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle. Vaccine 2004; 22: 2413-2419 [PMID: 15193403 DOI: 10.1016/j.vaccine.2003.11.065]
74. Gorski A, Dabrowska K, Switala-Jeleń K, Nowaczyk M, Weber-Dabrowska B, Boratynski J, Wietrzyk J, Opolski A. New insights into the possible role of bacteriophages in host defense and disease. Med Immunol 2003; 2: 2 [PMID: 12625836 DOI: 10.1186/1476-9433-2-2]
75. Hanlon GW. Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int J Antimicrob Agents 2007; 30: 118-128 [PMID: 17566713 DOI: 10.1016/j.ijantimicag.2007.04.006]
76. Clark JR, March JB. Bacterial viruses as human vaccines? Expert Rev Vaccines 2004; 3: 463-476 [PMID: 15270651 DOI: 10.1586/14760584.3.4.463]
77. Clark JR, Bartley K, Jepson CD, Craik V, March JB. Comparison of a bacteriophage-delivered DNA vaccine and a commercially available recombinant protein vaccine against hepatitis B. FEMS Immunol Med Microbiol 2011; 61: 197-204 [PMID: 21204995 DOI: 10.1111/j.1574-695X.2010.00763.x]
78. Miedzybrodzki R, Fortuna W, Weber-Dabrowska B, Gorski A. Bacterial viruses against viruses pathogenic for man? Virus Res 2005; 110: 1-8 [PMID: 15845250 DOI: 10.1016/j.virusres.2005.01.009]
79. Puntoriero G, Meola A, Lahm A, Zucchelli S, Ercole BB, Tafi R, Pezzanera M, Mondelli MU, Cortese R, Tramontano A, Galfre' G, Nicosia A. Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants. EMBO J 1998; 17: 3521-3533 [PMID: 9649423 DOI: 10.1093/emboj/17.13.3521]
80. Scala G, Chen X, Liu W, Telles JN, Cohen OJ, Vaccarezza M, Igarashi T, Fauci AS. Selection of HIV-specific immunogenic epitopes by screening random peptide libraries with HIV-1-positive sera. J Immunol 1999; 162: 6155-6161 [PMID: 10229859]
81. de la Cruz VF, Lal AA, McCutchan TF. Immunogenicity and epitope mapping of foreign sequences via genetically engineered filamentous phage. J Biol Chem 1988; 263: 4318-4322 [PMID: 2450091]
82. Menéndez T , De Haz I, Delgado M, Garay H, Martín A, Vispo NS. Immunisation with phage-displayed variable region 2 from meningococcal PorA outer membrane protein induces bactericidal antibodies against Neisseria meningitidis. Immunol Lett 2001; 78: 143-148 [PMID: 11578688 DOI: 10.1016/S0165-2478(01)00245-0]
83. Frenkel D, Katz O, Solomon B. Immunization against Alzheimer's beta-amyloid plaques via EFRH phage administration. Proc Natl Acad Sci USA 2000; 97: 11455-11459 [PMID: 11027345 DOI: 10.1073/pnas.97.21.11455]
84. Fang J , Wang G, Yang Q, Song J, Wang Y, Wang L. The potential of phage display virions expressing malignant tumor specific antigen MAGE-A1 epitope in murine model. Vaccine 2005; 23: 4860-4866 [PMID: 16029917 DOI: 10.1016/j.vaccine.2005.05.024]
85. Manoutcharian K, Díaz-Orea A, Gevorkian G, Fragoso G, Acero G, González E, De Aluja A, Villalobos N, Gómez-Conde E, Sciutto E. Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis. Vet Immunol Immunopathol 2004; 99: 11-24 [PMID: 15113650 DOI: 10.1016/j.vetimm.2003.12.009]
86. Tan GH, Yusoff K, Seow HF, Tan WS. Antigenicity and immunogenicity of the immunodominant region of hepatitis B surface antigen displayed on bacteriophage T7. J Med Virol 2005; 77: 475-480 [PMID: 16254965 DOI: 10.1002/jmv.20479]
87. Wan Y, Wu Y, Bian J, Wang XZ, Zhou W, Jia ZC, Tan Y, Zhou L. Induction of hepatitis B virus-specific cytotoxic T lymphocytes response in vivo by filamentous phage display vaccine. Vaccine 2001; 19: 2918-2923 [PMID: 11282203 DOI: 10.1016/S0264-410X(00)00561-2]
88. Manoutcharian K , Terrazas LI, Gevorkian G, Acero G, Petrossian P, Rodriguez M, Govezensky T. Phage-displayed T-cell epitope grafted into immunoglobulin heavy-chain complementarity-determining regions: an effective vaccine design tested in murine cysticercosis. Infect Immun 1999; 67: 4764-4770 [PMID: 10456929]
89. Hashemi H , Bamdad T, Jamali A, Pouyanfard S, Mohammadi MG. Evaluation of humoral and cellular immune responses against HSV-1 using genetic immunization by filamentous phage particles: a comparative approach to conventional DNA vaccine. J Virol Methods 2010; 163: 440-444 [PMID: 19903497 DOI: 10.1016/j.jviromet.2009.11.008]
90. Spear PG, Manoj S, Yoon M, Jogger CR, Zago A, Myscofski D. Different receptors binding to distinct interfaces on herpes simplex virus gD can trigger events leading to cell fusion and viral entry. Virology 2006; 344: 17-24 [PMID: 16364731 DOI: 10.1016/j.virol.2005.09.016]
91. De Berardinis P , Sartorius R, Fanutti C, Perham RN, Del Pozzo G, Guardiola J. Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses. Nat Biotechnol 2000; 18: 873-876 [PMID: 10932158 DOI: 10.1038/78490]
92. Folgori A, Tafi R, Meola A, Felici F, Galfré G, Cortese R, Monaci P, Nicosia A. A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera. EMBO J 1994; 13: 2236-2243 [PMID: 7514533]
93. Phalipon A, Folgori A, Arondel J, Sgaramella G, Fortugno P, Cortese R, Sansonetti PJ, Felici F. Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics. Eur J Immunol 1997; 27: 2620-2625 [PMID: 9368618 DOI: 10.1002/eji.1830271022]
94. Meola A , Delmastro P, Monaci P, Luzzago A, Nicosia A, Felici F, Cortese R, Galfrè G. Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage. J Immunol 1995; 154: 3162-3172 [PMID: 7534789]
95. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-252 [PMID: 9521319 DOI: 10.1038/32588]
96. Banchereau J, Schuler-Thurner B, Palucka AK, Schuler G. Dendritic cells as vectors for therapy. Cell 2001; 106: 271-274 [PMID: 11509176 DOI: 10.1016/S0092-8674(01)00448-2]
97. Curiel TJ, Morris C, Brumlik M, Landry SJ, Finstad K, Nelson A, Joshi V, Hawkins C, Alarez X, Lackner A, Mohamadzadeh M. Peptides identified through phage display direct immunogenic antigen to dendritic cells. J Immunol 2004; 172: 7425-7431 [PMID: 15187120]
98. Subramanya S, Kim SS, Abraham S, Yao J, Kumar M, Kumar P, Haridas V, Lee SK, Shultz LD, Greiner D, N M, Shankar P. Targeted delivery of small interfering RNA to human dendritic cells to suppress dengue virus infection and associated proinflammatory cytokine production. J Virol 2010; 84: 2490-2501 [PMID: 20015996 DOI: 10.1128/JVI.02105-08]
99. Lekkerkerker A, Logtenberg T. Phage antibodies against human dendritic cell subpopulations obtained by flow cytometry-based selection on freshly isolated cells. J Immunol Methods 1999; 231: 53-63 [PMID: 10648927 DOI: 10.1016/S0022-1759(99)00140-4]